FilingReader Intelligence
Amoy Diagnostics reports 31% profit jump in H1
July 28, 2025 at 09:22 AM UTC•By FilingReader AI
Amoy Diagnostics reported net profit rose 31.41% to 189.04 million yuan in the first half of 2025, while revenue increased 6.69% to 579.34 million yuan.
The company adjusted its restricted stock repurchase price from 11.62 yuan to 11.32 yuan per share following dividend payments.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Summary of the 2025 semi-annual reportJuly 28, 2025 at 08:00 AM UTC
Summary table of non-operating fund occupation and other related party fund transactions for the first half of 2025July 28, 2025 at 08:00 AM UTC
Announcement on the adjustment of matters related to the 2023 restricted stock incentive planJuly 28, 2025 at 08:00 AM UTC
Announcement of board resolutionsJuly 28, 2025 at 08:00 AM UTC
Announcement of supervisory board resolutionsJuly 28, 2025 at 08:00 AM UTC
Legal opinion on the adjustment of the repurchase price for the 2023 restricted stock incentive planJuly 28, 2025 at 08:00 AM UTC
SZSE:300685•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Amoy Diagnostics publishes news
Free account required • Unsubscribe anytime